Scarica l'app Stockscreener
9.71
4.24%
-0.43
Pre-mercato:
9.62
-0.09
-0.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Biohaven Ltd Borsa (BHVN) Ultime notizie
Biohaven Warns of Broad Operational, Financial and Market Risks, Affirms Overall Risk Profile Matches Prior 10-K Disclosures - TipRanks
Biohaven Expands At-The-Market Equity Offering Program - TipRanks
Biohaven (NYSE: BHVN) adds $350.0 million at-the-market share program - Stock Titan
Biohaven Ltd. (BHVN) upgraded to buy: Here's why - MSN
Biohaven Ltd. (BHVN) Upgraded to Buy: Here's Why - Yahoo Finance Australia
Biohaven: Buy Rating Reiterated as Analyst Sees Multiple Pipeline Catalysts and Maintains $21 Price Target - TipRanks
RBC Capital Maintains Biohaven(BHVN.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
Biohaven Ltd. Q1 2026 Financial Report: Key Highlights, Financial Statements, and Business Overview - Minichart
RBC Cuts Price Target on Biohaven to $22 From $23, Keeps Outperform, Speculative Risk - marketscreener.com
MSN Money - MSN
BofA Securities Maintains Biohaven(BHVN.US) With Hold Rating, Cuts Target Price to $12 - Moomoo
Biohaven Price Target Trimmed to $12 as Analyst Maintains Hold Amid Balanced Pipeline Upside and Financing Risks - TipRanks
Biohaven (BHVN) Is Up 5.7% After Narrower Q1 Loss And Pivotal Trial Plans – Has The Bull Case Changed? - simplywall.st
Biohaven Shareholders Back Board, Auditor and Executive Pay - TipRanks
Biohaven files for offering of up to $350 million common sharesSEC filing - marketscreener.com
Biohaven Ltd. (NYSE: BHVN) expands ATM program to $350M for common shares - Stock Titan
Biohaven (NYSE: BHVN) trims Q1 2026 loss and raises $178.9M - Stock Titan
Biohaven Pharma (BHVN) files mixed shelf - StreetInsider
Biohaven Ltd files for mixed shelf offering size not disclosedSEC filing - marketscreener.com
Biohaven Ltd. (NYSE: BHVN) files shelf to register shares, debt and warrants - Stock Titan
Earnings Flash (BHVN) Biohaven Ltd. Posts Q1 Adjusted Loss $0.69 per Share, Vs. FactSet Est of $-0.83 - Moomoo
Biohaven Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Biohaven (NYSE: BHVN) cuts Q1 2026 loss while funding late-stage drug pipeline - Stock Titan
Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results - ChartMill
Biohaven (NYSE: BHVN) shareholders back directors, auditors and pay plan - Stock Titan
Assessing Biohaven (BHVN) Valuation After Prolonged Share Price Weakness And Elevated P/B Ratio - simplywall.st
Biohaven Faces Catalyst-Rich 2H 2026 With Multiple Key Readouts Ahead - RTTNews
BHVN SEC FilingsBiohaven 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Biohaven (NYSE: BHVN) receives 68,693 stock options award - Stock Titan
Director Julia P. Gregory awarded 68,693 Biohaven (BHVN) stock options - Stock Titan
(BHVN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
BTIG Reiterates Biohaven (BHVN) Buy Recommendation - MSN
Biohaven (NYSE:BHVN) Trading Up 5.2%Here's What Happened - MarketBeat
BHVN Stock Price, Quote & Chart | BIOHAVEN LTD (NYSE:BHVN) - ChartMill
Biohaven Obesity Trial Milestone Puts Focus On Taldefgrobep And Valuation Gap - simplywall.st
Biohaven (NYSE:BHVN) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat
Biohaven (BHVN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Assessing Biohaven (BHVN) Valuation After Sharp One Month Rebound And Steep One Year Decline - simplywall.st
Biohaven Completes Enrollment for Obesity Drug Phase 2 Trial - HarianBasis.co
Moderate Buy Rating Seen For Biohaven Ltd. (BHVN) - Insider Monkey
Spinocerebellar Ataxias Pipeline Advances Toward - openPR.com
Biohaven (NYSE:BHVN) Shares Down 5.7%What's Next? - MarketBeat
Biohaven (BHVN) fuels confidence with encouraging azetukalner data - MSN
Canaccord Initiates Coverage of Biohaven Ltd. (BHVN) With a Buy Rating - Insider Monkey
Responsive Playbooks and the BHVN Inflection - Stock Traders Daily
Here is why Biohaven (BHVN) is among the top healthcare stocks insiders are buying - MSN
Biohaven (NYSE:BHVN) Upgraded by Wall Street Zen to Sell Rating - MarketBeat
Why Biohaven (BHVN) Is Up 10.6% After Bullish Analyst Coverage Of Late-Stage Pipeline Prospects - Sahm
Biohaven Receives 'Moderate Buy' Rating from Analysts - National Today
Biohaven Ltd. (NYSE:BHVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Biohaven: Downgrade To Hold On Troriluzole Setback And Obesity Data 2nd Half 2026 (BHVN) - Seeking Alpha
Biohaven reports details on discovery of BHV-2100 - BioWorld News
Biohaven (BHVN) Stock: Price-to-Value (On the Radar) 2026-04-15Real Trader Insights - Xã Thanh Hà
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):